1248 Management’s Boston Scientific BSX Stock Holding History

1248 Management’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$710K	Buy	11,322 +3,098	+38%	+$248K	0.33%	42
2025 Q4	$784K	Hold	8,224	–	–	0.42%	37
2025 Q3	$803K	Buy	8,224 +7,878	+2,277%	+$816K	0.45%	40
2025 Q2	$37.2K	Hold	346	–	–	0.01%	124
2025 Q1	$34.9K	Buy	+346	New	+$34.8K	0.01%	125

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

1248 Management's BSX Position: Q1 2026 in Review

1248 Management increased its Boston Scientific (BSX) stake by 38% in Q1 2026, buying an estimated $248K and bringing the position to 11,322 shares worth $710K. The position accounts for 0.33% of the portfolio, ranked #42.

1248 Management first reported a position in BSX in Q1 2025 and has held it in 5 quarters since. The position peaked at $803K in Q3 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

1248 Management held 11,322 shares of Boston Scientific worth $710K as of Q1 2026.
1248 Management bought 3,098 Boston Scientific shares in Q1 2026, an estimated $248K.
Boston Scientific made up 0.33% of 1248 Management's portfolio in Q1 2026, its #42 holding.
1248 Management first reported a position in Boston Scientific in Q1 2025 and has held it in 5 quarters since.
1248 Management's Boston Scientific position peaked at $803K in Q3 2025.
1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on 1248 Management's 13F filing for Q1 2026, filed 15 May 2026.